Category: Research
BU Researchers Help Develop First Therapies to Treat Sickle Cell Disease
For people with sickle cell disease, a group of inherited blood disorders, there’s new hope. The US Food and Drug Administration has approved two groundbreaking treatments—developed with the help of Boston University researchers.
BU Ecologist Lucy Hutyra Wins a 2023 MacArthur “Genius Grant”
Lucy Hutyra, a BU College of Arts & Sciences professor of Earth and environment, focuses on understanding the impacts of urbanization on climate and ecosystems. She is one of 20 fellows who has received a MacArthur “Genius Grant.”
Researchers Find Way to Tweak Immune System to Fight Tuberculosis
A Boston University–led research team has found a way to tweak immune cells to better fight tuberculosis that could be ready for clinical trials as soon as 2024. The researchers identified the genetic signatures of white blood cells and then tested the ability of different compounds to transform vulnerable cells into more resilient ones.
BU Ignition Awards Accelerate Products for Repairing Damaged Teeth, Fighting Cancer, and More
The BU Ignition Awards are designed to accelerate promising new science and technology. Among the 2023 winners are a tooth-saving formula, AI-powered reading tool, and cancer-fighting technology. Award winners receive coaching and support to bring their innovations to market.
BU Dark Matter Researcher Wins Award for Contributions to Experimental Physics
The Gordon and Betty Moore Foundation has named Boston University physicist Alex Sushkov to its 2023 cohort of Experimental Physics Investigators. The recognition is given to a select group of distinguished scientists who the organization hopes will make “extraordinary contributions to the field of experimental physics.” Sushkov will receive $1.25 million over five years to support his work on an imaging technique used to study the nuclei of atoms.
Royal Society of Chemistry Honors BU’s Mark Grinstaff
Chemist, biomedical engineer, and William Fairfield Warren Distinguished Professor Mark Grinstaff has won the Royal Society of Chemistry’s Centenary Prize in “recognition of brilliance in research and innovation.” The Centenary Prize is given to “outstanding chemists, who are also exceptional communicators, from overseas,” according to its website.
FDA Clears Bionic Pancreas Developed in BU Lab for People with Type 1 Diabetes
A bionic pancreas—a wearable, pocket-sized, automated insulin delivery device—that was first developed in a Boston University lab has been cleared by the US Food and Drug Administration (FDA). The iLet Bionic Pancreas is now commercially available, bringing fresh hope to the almost two million Americans with type 1 diabetes.
Ji-Xin Cheng Named BU’s Innovator of the Year
Moustakas Chair Professor in Photonics and Optoelectronics Ji-Xin has been named the 2022 Boston University Innovator of the Year. The College of Engineering professor of biomedical engineering, electrical and computer engineering, and materials science and engineering has a long list of trailblazing achievements, including inventing a way to use blue light and hydrogen peroxide to treat a drug-resistant skin infection called MRSA, finding molecular signatures associated with aggressive cancers for treatment and diagnosis, and creating novel imaging techniques using infrared light to see molecules inside living cells.
CAS’ Renato Mancuso Wins Gitner Family Award
Renato Mancuso was awarded the Gerald and Deanne Gitner Family Award for Innovation in Teaching with Technology. Mancuso received the award for designing a system that enables students to submit their coding assignments via a web-based interface and then view how their submission performs and compares to classmates’ work.
BU Researchers Join $100 Million Effort to Fight Future Deadly Pathogens
Boston University researchers are joining a $100 million effort to advance our understanding of dangerous pathogens—and help spur new ways to defeat or at least contain them. The Howard Hughes Medical Institute’s Emerging Pathogens Initiative, which is pulling in 70 scientists from 29 organizations, will include 7 BU researchers, who will be part of teams working on the next generation of RNA-based antiviral therapies and investigating microscopic pathogenic parasites called protozoa. BU’s share of the funding will be $16 million.
